Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nineteen…
The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPate…
Annual Drug Patent Expirations for GOCOVRI Gocovri is a drug marketed by Adamas Operations and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for Adamas Operations drug GOCOVRI appeared first …
Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There is…
The post New patent for Glaxo Grp drug ADVAIR HFA appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.…
The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on Dru…
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Annual Drug Patent Expirations for SINUVA Sinuva is a drug marketed by Intersect Ent Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Intersect Ent drug SINUVA appeared first on D…
New patent expiration for Intersect Ent drug SINUVA Read Post »
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Astrazeneca drug LYNPARZA app…
New patent expiration for Astrazeneca drug LYNPARZA Read Post »
This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their…
The post Pharmaceutical companies with the most ‘P…
Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs Read Post »
SINUVA (mometasone furoate) Intersect ent inc Patent: 7,951,131 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for…
Drug Patent Expirations for the Week of March 10, 2024 Read Post »
This chart shows the drugs with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Net…
Which pharmaceutical drugs have the most drug patents in Netherlands? Read Post »
NASCOBAL (cyanocobalamin) Endo pharms inc Patent: 7,404,489 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug …
Drug Patent Expirations for the Week of March 10, 2024 Read Post »